Taylor Morrison Home Statistics
Total Valuation
TMHC has a market cap or net worth of $6.15 billion. The enterprise value is $7.42 billion.
| Market Cap | 6.15B |
| Enterprise Value | 7.42B |
Important Dates
The next confirmed earnings date is Tuesday, April 30, 2024, before market open.
| Earnings Date | Apr 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TMHC has 106.43 million shares outstanding. The number of shares has decreased by -0.83% in one year.
| Shares Outstanding | 106.43M |
| Shares Change (YoY) | -0.83% |
| Shares Change (QoQ) | -1.83% |
| Owned by Insiders (%) | 2.80% |
| Owned by Institutions (%) | 100.33% |
| Float | 103.37M |
Valuation Ratios
The trailing PE ratio is 8.22 and the forward PE ratio is 7.58. TMHC's PEG ratio is 1.51.
| PE Ratio | 8.22 |
| Forward PE | 7.58 |
| PS Ratio | 0.83 |
| Forward PS | 0.82 |
| PB Ratio | 1.15 |
| P/FCF Ratio | 7.92 |
| PEG Ratio | 1.51 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.15, with an EV/FCF ratio of 9.60.
| EV / Earnings | 9.64 |
| EV / Sales | 1.00 |
| EV / EBITDA | 7.15 |
| EV / EBIT | 7.38 |
| EV / FCF | 9.60 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.40 |
| Debt / EBITDA | 2.03 |
| Debt / FCF | 2.72 |
| Interest Coverage | -79.86 |
Financial Efficiency
Return on equity (ROE) is 15.10% and return on invested capital (ROIC) is 10.16%.
| Return on Equity (ROE) | 15.10% |
| Return on Assets (ROA) | 9.00% |
| Return on Capital (ROIC) | 10.16% |
| Revenue Per Employee | $2.65M |
| Profits Per Employee | $274,618 |
| Employee Count | 2,800 |
| Asset Turnover | 0.87 |
| Inventory Turnover | 1.03 |
Taxes
In the past 12 months, TMHC has paid $248.10 million in taxes.
| Income Tax | 248.10M |
| Effective Tax Rate | 24.39% |
Stock Price Statistics
The stock price has increased by +40.24% in the last 52 weeks. The beta is 1.87, so TMHC's price volatility has been higher than the market average.
| Beta (1Y) | 1.87 |
| 52-Week Price Change | +40.24% |
| 50-Day Moving Average | 57.36 |
| 200-Day Moving Average | 49.68 |
| Relative Strength Index (RSI) | 47.50 |
| Average Volume (30 Days) | 774,917 |
Short Selling Information
The latest short interest is 2.65 million, so 2.49% of the outstanding shares have been sold short.
| Short Interest | 2.65M |
| Short Previous Month | 2.48M |
| Short % of Shares Out | 2.49% |
| Short % of Float | 2.56% |
| Short Ratio (days to cover) | 3.47 |
Income Statement
In the last 12 months, TMHC had revenue of $7.42 billion and earned $768.93 million in profits. Earnings per share was $6.98.
| Revenue | 7.42B |
| Gross Profit | 1.78B |
| Operating Income | 996.80M |
| Pretax Income | 1.02B |
| Net Income | 768.93M |
| EBITDA | 1.04B |
| EBIT | 1.00B |
| Earnings Per Share (EPS) | $6.98 |
Balance Sheet
The company has $807.10 million in cash and $2.10 billion in debt, giving a net cash position of -$1.30 billion or -$12.17 per share.
| Cash & Cash Equivalents | 807.10M |
| Total Debt | 2.10B |
| Net Cash | -1.30B |
| Net Cash Per Share | -$12.17 |
| Equity / Book Value | 5.31B |
| Book Value Per Share | 49.94 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was $806.17 million and capital expenditures -$33.43 million, giving a free cash flow of $772.74 million.
| Operating Cash Flow | 806.17M |
| Capital Expenditures | -33.43M |
| Free Cash Flow | 772.74M |
| FCF Per Share | $7.19 |
Margins
Gross margin is 24.04%, with operating and profit margins of 13.44% and 10.37%.
| Gross Margin | 24.04% |
| Operating Margin | 13.44% |
| Pretax Margin | 13.71% |
| Profit Margin | 10.37% |
| EBITDA Margin | 13.99% |
| EBIT Margin | 13.54% |
| FCF Margin | 10.42% |
Dividends & Yields
TMHC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.83% |
| Shareholder Yield | 0.83% |
| Earnings Yield | 12.56% |
| FCF Yield | 12.63% |
Analyst Forecast
The average price target for TMHC is $57.20, which is -1.02% lower than the current price. The consensus rating is "Buy".
| Price Target | $57.20 |
| Price Target Difference | -1.02% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |